Central Retinal Vein Occlusion: Clinical Trials

2 trials for Central Retinal Vein Occlusion, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 unknown. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Unknown 2

Follow Central Retinal Vein Occlusion: new trials by email Literature Review of Central Retinal Vein Occlusion trials Research Report on Central Retinal Vein Occlusion

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Hyperbaric Chamber for Central Retinal Vein Occlusion (CRVO) Patients
Hyperbaric chamber treatment - Central Retinal Vein Occlusion
Phase 2UnknownAssaf-Harofeh Medical Center202015-03-012015-04-01
Intravitreal Bevasizumab Versus Intravitreal Triamcinolone in Central Retinal Vein Occlusion (CRVO)
Bevasizumab, Triamcinolone Acetonide - Central Retinal Vein Occlusion
Phase 2UnknownShahid Beheshti University of Medical Sciences2010-01-012010-08-10

Narrower conditions

Retinal Vein Occlusion (2)

Broader conditions

Cardiovascular Diseases (2)  ·  Embolism and Thrombosis (2)  ·  Eye Diseases (2)  ·  Retinal Diseases (2)  ·  Thrombosis (2)  ·  Vascular Diseases (2)  ·  Venous Thrombosis (2)

Interventions

Triamcinolone Acetonide (1)

Sponsors

Assaf-Harofeh Medical Center (1)  ·  Shahid Beheshti University of Medical Sciences (1)

Countries

Iran (1)  ·  Israel (1)